ロード中...
Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is regarded as a leading cause of cancer-related deaths, and its progression is associated with hypoxia and the induction of hypoxia-inducible factor (HIF). Meloxicam, a selective cyclooxygenase-2 (COX-2) inhibitor, induces cell death in various malignancies. However,...
保存先:
| 出版年: | Oxid Med Cell Longev |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7128048/ https://ncbi.nlm.nih.gov/pubmed/32273947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7079308 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|